Select Page

The global monoclonal antibodies market is expected to grow at growth rate of 4.8% to reach USD 135.6 billion by 2025. This comprehensive study reveals the market estimate numbers for different market segments. Along with that, the study covers qualitative insights, strategic benchmarking and thorough competitive landscaping in the report spreading over 109 pages.

Antibodies and antibody fragments has become an essential tool for biomedical research and rapidly gaining popularity as therapeutic moiety globally. Constant increase inn therapeutic and diagnostic applications of mAbs is expected to contribute to the market development. In recent years, mAbs accounted for the largest share of all biologic therapies. The global market is categorized in terms of source, end use and diseases. Based on source, the market is divided in murine, chimeric, humanized and human. Murine segment is the lowest revenue generating segment, accounted for only 7.54% share of the global market in 2016. The adoption of murine antibodies as therapeutics is limited by their immunogenicity as the mouse antibodies are seen by human systems as a foreign particle.

To request free sample copy:

In terms of diseases, the market is segmented as autoimmune diseases, inflammatory diseases, Infectious diseases and others. Cancer segment dominated the market. Avastin, Heceptin and Rituxan are the highest selling monoclonal antibody therapeutics for the treatment of cancer. However, sale of monoclonal antibodies for infectious diseases, arthritis and inflammatory diseases also growing at decent growth rate owing to the expected approval of novel mAb therapeutics in coming years. End user segment is divided as hospitals, research laboratories and others.
Regionally, developed regions such as North America and Europe are considered to be the largest market. Of which, North America accounted for almost 50% share of the global market in 2016. Increasing number of approvals and favorable government support augment the market growth in developed region. Asia Pacific region is expected to growth at CAGR of 9.98% during the future period. Companies such as F. Hoffmann-La Roche Ltd.; GlaxoSmithKline plc, Novartis AG; Pfizer; Shanghai Junshi Bioscience Co., Ltd, Daiichi Sankyo Company, Ltd., and others are operating in this market.

Browse full report with in-depth ToC on “Monoclonal Antibodies Market, By Source (Murine, Chimeric, Humanized and Human), By Diseases (Autoimmune, Inflammatory, and Infectious), By End User, And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025” at

The scope of this report covers the market by its major segments, as follows:

Market, by Source: Murine, Chimeric, Humanized and Human; Market, by Disease: Murine, Chimeric, Humanized and Human;

Market, by End Use: Hospitals and Research labs;

Market, by Region: North America, Europe, Asia Pacific, Latin America, Middle East and Africa and Rest of the World; Market, by Country: U.S., Canada, Germany, France, India, and China;

Key players profiled in this report with special attention on competitive landscape includes, (can be further customized to include additional 10 profiles of companies):
Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Novartis AG
Pfizer, Inc.
Shanghai Junshi Bioscience Co., Ltd
Daiichi Sankyo Company, Ltd.
Bristol-Myers Squibb Company

Key benefits of the report:
• The report presents a macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
• A thorough analysis of relevant statistical data to estimate the market paradigms
• Exceptional understanding of region and country-specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts segmentations, and growth specific to the countries.
• Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments

Find out more by getting in touch:

About Us:
AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends for various industries such as Healthcare, Bulk Chemicals, Semiconductors, Electronics, and Foods and Beverages.

Contact us:
Mr. Jose (Press & Marketing Manager)
Corporate Sales, USA
AnalystView Market Insights
Tel: +91-757-498-5725 (Asia-Pacific Business Centre)